InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-31.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Explore the complete record of transactions filed by Schwartz Elissa J., Director. Insider active across 1 company, notably Galectin Therapeutics INC. Aggregated, 1 reports have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €2k. History available since 21 January 2022. The latest transaction was filed on 21 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Schwartz Elissa J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
1,000 shares@ US$2.00100.0% of flowCommon StockSEC:0001133416-22-000012:0
Canonical exit: 21 Apr 2022 (T+90)
1 of 1 declaration
About Schwartz Elissa J.
Elissa J. Schwartz is a Director at GALECTIN THERAPEUTICS INC. She is involved in strategic decision-making and overseeing the company's activities. Her experience and knowledge of the industry are valuable assets in guiding GALECTIN THERAPEUTICS towards its goals.
